Factor XIII (plasma transglutaminase, fibrin stabilizing factor) is a glycoprotein that circulates in blood as a tetramer (a2b2) consisting of two a and two b subunits. The primary structures of the a and b subunits of human factor XIII have been reported by a combination of cDNA cloning and amino acid sequence analysis. To establish the gene structure of the a subunit for factor XIII, several human genomic libraries were screened by using the cDNA encoding the a subunit as a probe. Among -5 X 107 recombinant phage, 121 have been shown to contain an insert encoding a portion of the a subunit. Twenty-five unique clones were then characterized by restriction mapping, Southern blotting, and DNA sequencing. Overlapping clones encoding the a subunit of factor XIII span >160 kilobases. The gene was found to contain 15 exons separated by 14 introns. All the sequences of the introns at the intron-exon boundaries were GT-AG, which are the same as those found in other eukaryotic genes. DNA sequence analysis revealed that the activation peptide released by thrombin, the active site cysteine region, the two putative calcium-binding regions, and the thrombin cleavage site leading to inactivation are encoded by separate exons. This suggests that the introns may separate the a subunit into functional and structural domains. A comparison of the amino acid sequence deduced from the genomic DNA sequence with those deduced from cDNA or determined by amino acid sequence analysis of the plasma and placental proteins revealed apparent amino acid polymorphisms in six positions of the polypeptide chain of the a subunit.
ABSTRACT
Factor XIII (plasma transglutaminase, fibrin stabilizing factor) is a glycoprotein that circulates in blood as a tetramer (a2b2) consisting of two a and two b subunits. The primary structures of the a and b subunits of human factor XIII have been reported by a combination of cDNA cloning and amino acid sequence analysis. To establish the gene structure of the a subunit for factor XIII, several human genomic libraries were screened by using the cDNA encoding the a subunit as a probe. Among -5 X 107 recombinant phage, 121 have been shown to contain an insert encoding a portion of the a subunit. Twenty-five unique clones were then characterized by restriction mapping, Southern blotting, and DNA sequencing. Overlapping clones encoding the a subunit of factor XIII span >160 kilobases. The gene was found to contain 15 exons separated by 14 introns. All the sequences of the introns at the intron-exon boundaries were GT-AG, which are the same as those found in other eukaryotic genes. DNA sequence analysis revealed that the activation peptide released by thrombin, the active site cysteine region, the two putative calcium-binding regions, and the thrombin cleavage site leading to inactivation are encoded by separate exons. This suggests that the introns may separate the a subunit into functional and structural domains. A comparison of the amino acid sequence deduced from the genomic DNA sequence with those deduced from cDNA or determined by amino acid sequence analysis of the plasma and placental proteins revealed apparent amino acid polymorphisms in six positions of the polypeptide chain of the a subunit.
Factor XIII (plasma transglutaminase, fibrin stabilizing factor, or fibrinoligase) is a plasma protein that plays an important role in the final stages of blood coagulation and the regulation of fibrinolysis. The protein circulates in blood as a tetramer (a2b2; Mr, -320,000) consisting of two a subunits (Mr, -75,000 each), and two b subunits (Mr, -80,000 each), held together by noncovalent bonds (1) .
Thrombin that is generated during the blood coagulation cascade converts factor XIII from a proenzyme to factor XIIIa, a transglutaminase, in the presence ofcalcium ions and fibrin (2, 3) . Factor XIIIa then catalyzes the cross-linking between fibrin monomers (2) and between fibrin and a2-plasmin inhibitor (4) , leading to the formation of intermolecular e-(y-glutamyl)lysine bonds. These reactions result in a fibrin clot with considerable mechanical strength and an increase in resistance to proteolytic degradation by plasmin. The cross-linking of fibronectin to fibrin or to collagen is also catalyzed by factor XIIIa (5, 6) , and this reaction appears to be important in wound healing. Accordingly, a deficiency of factor XIII results in a severe lifelong bleeding tendency, defective wound healing, and habitual abortion (7, 8) . Congenital factor XIII deficiency is inherited in an autosomal recessive manner (8) .
Recently, we have determined the primary structure of both the a and b subunits of human factor XIII by a combination of cDNA cloning and amino acid sequence analysis (9, 10) . The primary structure of the a subunit has also been reported by Takahashi et al. (11) and Grundmann et al. (12) . The gene for the a subunit is located on chromosome 6 at p24-25 (13) , while that of the b subunit has not been reported thus far.
The availability of cDNAs encoding for the a and b subunits of factor XIII makes it possible to isolate and characterize the human genes encoding each of these two subunits. This is essential to study the regulation of the biosynthesis of the a and b subunits and to compare these subunits with abnormal genes. In the present studies, the flanking regions, the exons, and the intron-exon boundaries for the gene encoding the a subunit are presented.* (14) , EMBL3 (15) , and AgtWES (16) were kindly provided by Tom Maniatis, Shinji Yoshitake, and Barbara Schach, respectively.
MATERIALS AND METHODS
Oligonucleotides were synthesized by using a nucleotide synthesizer (Applied Biosystems, Foster City, CA) and were kindly supplied by Patrick S. H. Chou and Yim Foon Lee (University of Washington).
Phage from human genomic libraries were screened primarily by the in situ hybridization technique with four different EcoRI fragments from the cDNA encoding the a subunit of factor XIII (9) . To obtain clones that contain certain exons, appropriate restriction fragments from cDNAs or synthetic oligonucleotides were used for further screening or for identification of isolated clones by Southern blot analysis.
Phage DNA was prepared by the liquid culture lysis method (17) , followed by centrifugation and banding on a cesium chloride step gradient (18) . Genomic DNA inserts were isolated by digestion of the phage DNA with EcoRI and/or Sal I endonucleases and then subcloned into plasmid -IR n S E T S R T R F G G A A A U P P N N S N A A GRCCTTGT RARGTCRARA ATG TCR GAR ACT TCC RGG RCC GCC TTT GGR GGC AGA AGA GCR OTT CCA CCC RAT ARC TCT RAT GCR
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[ GT CAR GAR GAR GRG AGA TTG GCC CTR GAR ACT GCC CTG RTG TAC GGR OCT RAR RAG CCC CTC RAC RCR GAR GOT GTC RTG TRATCTCTCC ACCTTCCRAR GRGTGCTRARG  CRTTRGCTTT RRTTRRGCTC TCRTRGCTCR TRRGRGTRAC RGTCRTCRTT TRTCRTCRCR RRTGGCTRCR TCTCCRARTA TCRGTGGGCT CTCTTRCCAG  GGRGRTTTGC TCRRTRCCTG GCCTCRTTTR RARCROGACT TCRGRTTCCC CRCTCRGCCT TTTGGGRRTA RTRGCRCRTG RTTTGGGCTC TRGRRTTCCR  GTCCCCTTTC TCGGGGTCAG GTTCTACCCT CCRTGTGRGA RTRTTTTTCC CRGGRCTRGR GCACARCRTA RTTTTTRTTT TTGGCARRGC CRGRRARRRG  TCTTTCRTTT TGCRCCTGCR GCCRRGCRRR TGCCTGCCAR RTTTTRGRTT TRCCTTGTTR GRRROGGTGG CCCCATRTTA RCRRRTTGCR TTTOTGGGRR  RCTTRACCRC CTACRAGGRG RTRAGRARGC RGGTGCRRCA CTCRRGTCTR TTGARTRRTG TRGTTTTGTG RTGCRTTTTR TRGRRTGTGT CRCACTGTGG   CCTGRTCROC RGGRGCCART RTCCCTTRCT TTRRCCCTTT CTGGGRTGCR RTRCTRGGRA GTRRGTGRAR GRRTTTRTCT CTTTRGTTRG TGRTTRTRTT   TCACCCRTCT CTCRGGRRTC RTCTCCTTTG CAGRTORTG CRGGTTCAGG TCCCCTTTCR GRGRTATART ROGCCCARCA RGTTGRRGRR GCTGGCGGRT  CTRGTGRCCR GATATATRGR RGGACTGCRG CCRCTGRTTC TCTCTTGTCC TTCRCRTCRC CCRTTTTGRG RCCTCAGCTT GGCRCTCRGG TGCTGRRGGG   TRATRTGGRC TCAGCCTTGC ARATRGCCAG TGCTRGTTCT GRCCCRRCCR CRAGRGRTGC TGRCRTCRTT TGTRTTRTGT TCCARGGCTR CTRCRGRGRAR  GGCTGCCTGC TRTGTRTTTG CRARGGCTGRT TTRTGGTCRG RRTTTCCCTC TGRTRTGTCT AGGGTGTGAT TTAGGTCRGT RGACTGTGRT TCTTRGCRAA  RARTGRARCAG TGRTRRGTAT noncoding region and sequences that are apparently involved in mRNA processing are also underlined. The 5' and 3' ends of each exon are enclosed in brackets, as well as the site of polyadenylylation at the 3' end of the gene. The single-letter code for amino acids is used. pUC18 or pUC19. Additional restriction fragments from the performed to generate fragments that provided overlapping inserts were also subcloned into M13mpl8 or M13mpl9 to sequences with restriction fragments (21) . Oligonucleotides obtain overlapping sequences. The genomic DNA inserts were also synthesized as sequencing primers to obtain DNA were then sequenced by the dideoxy method (19) (14), and seven clones containing exons V and VI were isolated from 3 x 106 phage of a AgtWES size-fractionated library (3.9-to 5.0-kilobase EcoRI fragments) (16) . Of these 121 clones, 25 were found to be unique by restriction digestion and Southern blotting analysis. DNA sequence analysis of selected clones revealed that the 5' and 3' portions of the cDNA for the a subunit were present in the genomic clones (9, 12) . DNA sequence analysis also confirmed that these genomic clones contained all the exons that encode the cDNA sequence, as described below. The DNA sequence of 7156 nucleotides encoding the a subunit of human factor XIII and the flanking region of the gene is shown in Fig. 1 . This sequence extended 1000 base pairs (bp) upstream from the guanine labeled as nucleotide 1. This guanine corresponds to the fourth nucleotide in the 5' noncoding region of the cDNA obtained from a human placental library (9) . Comparison of the DNA sequence of the gene with the cDNA sequence (9, 12) indicated that the gene consisted of 15 exons (I-XV) interrupted by 14 introns (A-N). The first intron was present in the 5' noncoding region. The sequence of all the intron-exon splice junctions agrees with the GT-AG rule of Breathnach et al. (22) and with the consensus sequence of Mount (23) . Seven of the splice junctions (introns B, C, D, G, I, K, and L) are classified as type I, while four (introns E, F, J, and M) are type 0, and two (introns H and N) are type II (24) . The exons vary considerably in size, ranging from 89 to 1688 nucleotides. At the present time, it is not known how far the gene extends upstream from nucleotide 1 since a cDNA containing an extended 5' noncoding region has not been isolated. Exon XV is the largest of the 15 exons. This exon includes the coding region for the C terminus of the protein and the 3' noncoding region of the gene. The average size of the exons was 268 bp, excluding exon I, which is not known. This is somewhat larger than the average size of 150 bp found in other eukaryotic genes (25) . The overlapping clones spanned >160 kilobases, but contained gaps within introns B, D, F, H, Table 1 . Apparent polymorphisms in the amino acid, cDNA, human factor XIII J, and M. Accordingly, the size of the gene for the a subunit of factor XIII is substantially greater than 160 kilobases.
The DNA sequence analysis revealed that the 5' flanking region of the gene for the a subunit contained regulatory elements for transcription (26) , including a reverse "CCA-AT" box 210 bp prior to nucleotide 1 (Fig. 1) . These sequences have been shown to be functional in either orientation (27) . Also, three "TATA"-like sequences, GATAA, TAGAA, and TTTAA, were present 170, 150, and 40 bp upstream from nucleotide 1, respectively. At present, it is not known whether any of these sequences function as a promoter element. Several "GC" clusters were also present in the 5' flanking region of the gene for the a subunit of factor XIII. None of these sequences, however, is a typical "GGGCGG" sequence (26) . Although the a subunit is secreted into blood, the 5' end of the cDNA encoding the protein did not contain a typical hydrophobic leader sequence (10, 12) . A search for a possible leader sequence in the 5' flanking region and intron A of the genomic DNA also has been unsuccessful.
A dinucleotide of TA was found 14 bp downstream from the conserved AATAAA sequence for the polyadenylylation signal at the 3' end of the gene. The dinucleotides T(A) and C(A) are preferred as sites for polyadenylylation in eukaryotic genes (28) . Sequences surrounding the poly(A) site are also thought to play a role in polyadenylylation and mRNA processing. A potential CAYTG (y, pyrimidine) signal (29) was present beginning 6 bp upstream from the poly(A) site that was identical for 4 of 5 nucleotide positions. Also, a U4 homology sequence (30) was present 19 bp downstream from the poly(A) site and this sequence was identical for 13 of 18 nucleotides. A consensus sequence of YGTGTTYY, which is required for efficient formation of the 3' terminus of mRNA, was not found within 30 nucleotides downstream from the AATAAA sequence (31) .
Intron A in the 5'-noncoding region is located 18 nucleotides prior to the codon for the initiator methionine (Fig. 1) . Accordingly, exon I consists entirely of the 5' noncoding region. Intron B interrupts the codon for the amino acid that is six residues downstream from the cleavage site for activation by thrombin (between Arg-37 and Gly-38). Thus, the entire activation peptide region (amino acids 1-37) is encoded by exon II. The active site Cys-314 region is encoded by exon VII surrounded by introns F and G. This active site region of the a subunit is very similar to that of human tissue transglutaminase (9) . The region encoding the thrombin cleavage site leading to inactivation (between Lys-513 and Ser-514) (11) is encoded by exon XII. Two putative calcium-binding sites (flanking Gly-251 and Gly-473) are encoded by exon VI and XI, respectively. These data suggest that introns may separate the gene for the a subunit of factor XIII into exons encoding functional and structural domains (32, 33 (36) . Several differences were found when the DNA sequence of the gene for the a subunit of human factor XIII was compared to that of several cDNAs isolated in different laboratories (9, 12) . These differences included three nucleotide substitutions in the 3' noncoding region in which G, G, and A located 160, 996, and 1187 bp downstream from the stop codon in the cDNA were replaced by A, T, and T in the gene, respectively.
These changes, however, do not result in an amino acid change in the protein. Also, a G located 798 bp downstream from the stop codon was absent in the gene. Lastly, the first three nucleotides (CGG) in the 5' noncoding region of the cDNA (9) were not present in the genomic DNA sequence for the a subunit established in the present studies. It is very likely that these nucleotides were part of the EcoRI linker (GAATTCGGG) used for construction of the cDNA library. It is also possible, however, that another intron is present in the 5' noncoding region of the gene for the a subunit, and the sequence of AGGA at nucleotide 5 may act as a splice acceptor.
It was also shown by restriction digestion of the genomic clones that apparent polymorphisms exist in the gene for the a subunit. One EcoRI site in intron F was not present in one of the genomic clones, and this clone has an additional BamHI site in intron F that does not exist in the other clones. Another EcoRI site was found in both exon XII and a cDNA previously reported from our laboratory (9) , while the cDNA of Grundmann et al. (12) lacked this site. These apparent restriction fragment length polymorphisms may be helpful in studying various normal and abnormal genes.
Several changes in the genomic DNA sequence result in the substitution of amino acids that are different from that deduced by the cDNA (9, 12) and determined by amino acid sequence analysis of the plasma protein (9) or placental protein (11) ( Table 1) . Using agarose gel electrophoresis, several variant alleles for the a subunit of factor XIII have been reported in the normal population (37) . The substitution of a charged residue, such as Arg-77 or Glu-651, for an uncharged residue (Table 1 ) may contribute to the differential electrophoretic mobility of the gene products and may be related to the heterogeneity of the a subunit.
Microheterogeneity ofthe b subunit for factor XIII has also been classified into several alleles (38) . However, no polymorphisms in its amino acid and DNA sequences have been found thus far (10) .
